The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Digital Therapeutics For Fibromyalgia Market In 2026 And 2030?
The market for digital therapeutics addressing fibromyalgia has experienced rapid expansion in recent years. This sector is forecast to expand from $1.19 billion in 2025 to $1.44 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 21.1%. The growth observed in preceding periods can be linked to an increasing understanding of fibromyalgia management requirements, the growing uptake of digital health solutions, a rise in smartphone penetration within healthcare, the expansion of telehealth offerings, and the inherent limitations of conventional pain management approaches.
The digital therapeutics for fibromyalgia market is projected to experience substantial expansion in the coming years, reaching a valuation of $3.07 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.8%. This anticipated growth throughout the forecast period stems from factors such as a heightened demand for tailored chronic pain management solutions, the increasing incorporation of AI for therapy optimization, the broadening scope of remote care reimbursement structures, an intensified emphasis on personalized treatments informed by data, and improved partnerships between healthcare professionals and digital health companies. Key trends during this period are expected to encompass the growing uptake of mobile therapies for symptom tracking, a greater reliance on customized digital care strategies, the enhanced connectivity of wearables with therapeutic platforms, the expansion of remote patient monitoring initiatives, and a stronger emphasis on improving patient involvement and adherence to treatment.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29026&type=smp
Which Primary Drivers Are Impacting The Digital Therapeutics For Fibromyalgia Market Growth?
Increasing understanding of digital health tools is anticipated to fuel the expansion of the digital therapeutics for fibromyalgia market in the future. These solutions comprise software-driven tools and services, including patient applications, portals, and virtual care platforms, which provide information, monitoring, and therapeutic interventions via digital avenues. This heightened awareness stems from government-supported initiatives and the broad uptake of official health apps, which normalize receiving healthcare online. Digital therapeutics for fibromyalgia capitalize on this familiarity by engaging patients through these accustomed channels, simplifying the process of starting and adhering to app-based cognitive behavioral therapy, pacing, and sleep programs, all while allowing for supervision by clinicians. For example, data from December 2023 by the National Health Service, a UK government department, shows that users of digital health apps hit 33.6 million, an increase from 16.8 million in 2022, and monthly logins saw a 54% surge from 16.8 million to 25.8 million. Consequently, the expanding recognition of digital health solutions is propelling the digital therapeutics for fibromyalgia market.
How Is The Digital Therapeutics For Fibromyalgia Market Broken Down By Segment Categories?
The digital therapeutics for fibromyalgia market covered in this report is segmented –
1) By Product Type: Software Applications, Devices, Platforms
2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
3) By Distribution Channel: Online, Offline
4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
5) By End-User: Hospitals, Clinics, Homecare, Other End-Users
Subsegments:
1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms
Which Trends Are Guiding The Direction Of The Digital Therapeutics For Fibromyalgia Market?
Leading companies in the digital therapeutics for fibromyalgia market are emphasizing technological advancements, particularly computerized behavioral therapy devices, to deliver evidence-based interventions. These interventions aim to enhance pain management, alleviate fatigue, improve sleep quality, and support mental health through scalable, patient-centric digital platforms. A computerized behavioral therapy device is defined as a software-based digital platform or application that provides structured, evidence-backed cognitive or behavioral therapy interventions to patients remotely, often incorporating interactive modules, exercises, and real-time feedback to manage symptoms of conditions such as fibromyalgia. For example, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, introduced Stanza subsequent to receiving U.S. FDA De Novo marketing authorization (DEN220083). Stanza delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial detailed in The Lancet indicating significant clinical improvements. This program is provided via smartphone (iOS or Android), allowing patients convenient, in-app, at-home therapy.
Which Players Are Present In The Digital Therapeutics For Fibromyalgia Market Space?
Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx
Get The Full Digital Therapeutics For Fibromyalgia Market Report:
Which Region Holds The Highest Market Share In The Digital Therapeutics For Fibromyalgia Market?
North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for fibromyalgia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Digital Therapeutics For Fibromyalgia Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Digital Therapeutics For Fibromyalgia Market 2026, By The Business Research Company
Fibromyalgia Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report
Digital Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
Digital Health In Neurology Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-health-in-neurology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model